INVESTORS & MEDIA
News Release
Regeneron Announces September 2012 Investor Conference Presentations
Robert W. Baird Healthcare Conference at1:20 p.m. Eastern Time onWednesday, September 5, 2012 Morgan Stanley Global Healthcare Conference at3:55 p.m. Eastern Time onTuesday, September 11, 2012 UBS Global Life Sciences Conference at7:30 a.m. Eastern Time onThursday, September 20, 2012
The sessions may be accessed through the Company's web site, www.regeneron.com, on the Events and Presentations page. Archived versions of the presentations will be available for thirty days after the live webcasts.
Regeneron is a fully integrated biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets three products in
Contact Information: |
|
|
|
Investor Relations |
Corporate Communications |
914-847-5126 |
914.847.7640 |
SOURCE
News Provided by Acquire Media